Doctors can now prescribe puberty blocking medication to children under the age of 16 without a judge’s approval, Britain’s Court of Appeal ruled on Friday.
The decision reverses last year’s ruling that children seeking gender reassignment aren’t mature enough to give informed consent to take puberty blocking medicine, The Associated Press reported. The decision said that doctors should seek court approval before prescribing the medication because the drugs were still experimental.
SUCCESS! Bell v Tavistock has been overturned in the Court of Appeal. This is a huge win for trans people, trans youth and their families in particular
— Gendered Intelligence (@Genderintell) September 17, 2021
We have a shorter ‘quick read’ blog piece here on the Court of Appeal’s decision here (396 words)https://t.co/ZnsJAIekzb pic.twitter.com/7J2IvoZcKF
The Tavistock and Portman National Health Service trust, Britain’s only gender identity development service for children, appealed last year’s ruling, the AP reported. The Court of Appeal sided with the trust Friday, ruling it was “inappropriate” for the high courts to issue their guidance, and it was up to the doctors to “exercise their judgment” regarding patients’ consent.
The trust agreed with the ruling highlighting “it affirms that it is for doctors, not judges, to decide on the capacity of under-16s to consent to medical treatment,” the AP reported.
The initial lawsuit against Tavistock clinic was filed by Keira Bell, a 24-year-old woman who was given puberty blockers when she was 16 years old before changing genders, the AP reported. Bell believed that the Tavistock clinic should have challenged her decision to become a male.
Bell argued that children going through puberty are “not capable of properly understanding the nature and effects of hormone blockers,” according to the AP.
Puberty blockers are drugs that temporarily pause puberty, suppressing the body’s release of sex hormones like testosterone and estrogen, according to the Mayo Clinic. Transgender children use the drug to delay the development of specific sex-related characteristics.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities for this original content, email licensing@dailycallernewsfoundation.org.
Have an opinion about this article? To sound off, please email letters@DailySignal.com and we’ll consider publishing your edited remarks in our regular “We Hear You” feature. Remember to include the URL or headline of the article plus your name and town and/or state.